Drugs / ASP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00853008 | Jan 2003 → Nov 2012 | acute lymphoblastic leukemia | PETHEMA Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00853008 ↗ |
| Route | Intravenous | “25,000 IU/m2, IV, d5 in consolidation (cycle 1, 2, 3)” NCT00853008 ↗ |